ECD Auto Design, the premier builder of custom one-of-one luxury vehicles, proudly announces the debut of its latest ...
The solar technology company Sono Group N.V. (OTCQB: SEVCF) (hereafter referred to as “Sono” or the “Company”, parent company to Sono Motors GmbH or “Sono Motors”) today issued an update to the ...
The BougeRV CR22 12V Refrigerator offers a practical solution for keeping food fresh on the go. Built with compressor refrigeration technology, it can cool down to 32°F in just 15 minutes and even ...
Our aim is to leverage our unrivaled experience and help customers across the globe unlock access to abundant LNG supply ... LNG carrier candidates and is analyzing cost-efficient conversion options ...
Dragon scale shingles wrap the turret of this turn-of-the-last-century Queen Anne Victorian, but it’s the contemporary conversion of ... recessed lighting, a gas fireplace nestled in a shiplap ...
LONDON, UK, Nov. 07, 2024 (GLOBE NEWSWIRE ... expand their reach in the finance and insurance industries with a 10% conversion guarantee for Top Funnel Live leads. This offer, designed to ...
The Patriots have committed seven turnovers in Drake Maye’s three-plus games (not counting the garbage time against the Jets), but the team and the fan base will live with it because he’s a ...
2024 (GLOBE NEWSWIRE) -- AdSure, a leading performance-based lead generation agency based in London, is offering new advertisers an exclusive opportunity to expand their reach in the finance and ...
Additionally, disinterested shareholders approved Equinox Partners Investment Management LLC ("Equinox") becoming a new "Control Person" of the Company upon conversion of outstanding Debentures.
OXFORD, United Kingdom, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), today announced the most significant data so far from the ongoing Phase 2b HBV003 clinical ...
Two participants who discontinued NUC therapy seroconverted to HBsAb positivity. OXFORD, United Kingdom, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS), today announced ...